Implanet S.A. (EPA:ALIMP)
France · Delayed Price · Currency is EUR 0.2300
-0.0080 (-3.36%)
Jan 12, 2026, 11:43 AM CET
Implanet Market Cap
Implanet has a market cap or net worth of €29.89 million as of January 12, 2026. Its market cap has increased by 109.83% in one year.
Market Cap
29.89M
Enterprise Value
35.51M
Revenue
11.10M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.23
Market Cap Chart
Since November 25, 2013, Implanet's market cap has decreased from 107.08M to 29.89M, a decrease of -72.08%. That is a compound annual growth rate of -9.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 29.89M | 19.90% |
| Dec 31, 2025 | 24.93M | 75.00% |
| Dec 31, 2024 | 14.25M | 442.72% |
| Dec 29, 2023 | 2.62M | -47.64% |
| Dec 30, 2022 | 5.01M | 23.77% |
| Dec 31, 2021 | 4.05M | -24.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 125.76B |
| Sanofi | 100.86B |
| Sartorius Stedim Biotech | 21.47B |
| bioMérieux | 13.42B |
| Eurofins Scientific SE | 12.17B |
| Ipsen | 10.40B |
| ABIVAX Société Anonyme | 7.72B |
| Virbac | 3.03B |